Litcius/Paper detail

Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury

Zhenhong Liu, Pengwen Wang, Shanshan Lu, Rong Guo, Wei Gao, Haiying Tong, Yin Yin, Xuezhen Han, Tiantian Liu, Xiangyun Chen, Michael X. Zhu, Zhen Yang

2020Cell Calcium81 citationsDOI

Topics & Concepts

TRPV1LiquiritinChemistryPharmacologyCapsazepineGlycyrrhiza uralensisInflammationBronchoalveolar lavageDownregulation and upregulationLipopolysaccharideBiochemistryTransient receptor potential channelLungImmunologyMedicineInternal medicineReceptorPathologyChromatographyGeneAlternative medicineHigh-performance liquid chromatographyIon Channels and ReceptorsPharmacological Effects of Natural CompoundsHerbal Medicine Research Studies
Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury | Litcius